NCT00002233View on ClinicalTrials.gov

A Study of a Combination of Four Drugs in Patients With Recent HIV Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Abacavir sulfate

DRUG

Amprenavir

DRUG

Lamivudine

Trial Locations (2)

10021

Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, New York

02906

Miriam Hosp / Family Healthcare Ctr at SSTAR, Providence

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002233 - A Study of a Combination of Four Drugs in Patients With Recent HIV Infection | Biotech Hunter | Biotech Hunter